|
Persons Mentioned
|
Dunn, William L., Jr.; Ellis, Cathy Lynn, Ph.D.; Hauserman, Max; Houghton, Kenneth S., Ph.D.; McDowell, W.W.; Osdene, Thomas Stafford, Ph.D.; Ryan, Frank J.
|
|
Description
|
The witness, former Director of Applied Research at Philip Morris, continued his testimony for the plaintiffs. He provided details of the Pandora study, which examined the occlusion of ventilation holes while the products were smoked. He said that one of his most important contributions was his role in the development of the Cambridge filter, which virtually eliminated tar. He feels that the design changes could have led to a great reduction in the risk of lung cancer and saved millions of lives. There would still have been a risk of heart disease, but this could have been addressed by using the nicotine analogs that he had developed. However, Philip Morris did not pursue this new technology and the witness believes that the reason was that they did not want to jeopardize Marlboros number one spot in the marketplace. He therefore believes that Philip Morris did not meet the standard of care of a reasonable manufacturer. The witness believes that his outspokenness on the issue of smoking disease and smoking addiction played a role in his termination.
|
FARONEW022002PM
Contact Us |
Legal |
Privacy |
Site Map |
Sponsors |
UCSF Tobacco Control Archives
